Bio Green Med Solution, Inc.
1.8000-0.01 (-0.55%)
Oct 29, 4:00:02 PM EDT · NasdaqCM · BGMS · USD
Key Stats
Market Cap
5.29MP/E (TTM)
0.00Basic EPS (TTM)
7123.50Dividend Yield
0%Recent Filings
8-K
Sells Plogosertib assets for $300K
Bio Green Med Solution sold its Plogosertib assets, including all patent rights for the PLK1 inhibitor targeting advanced cancers and hematological malignancies, to Tethra Biosciences for $300,000 upfront, with a potential $170,000 milestone. The deal closed on October 6, 2025, shedding non-core IP to streamline operations. This divestiture nets immediate cash while tying future upside to buyer's development success.
8-K
Preferred dividend declared
Bio Green Med Solution declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock on October 7, 2025. Payable November 1 to holders of record October 20, this payout underscores steady commitment to preferred shareholders amid Nasdaq listing. No changes to common stock dividends.
8-K
Board director resigns, new appointment
Bio Green Med Solution's board saw a swift change on September 19, 2025, when independent director Kwang Fock Chong resigned without disagreements, followed by the appointment of Soon Ping ('Zara') Pappas as his replacement effective September 23. Pappas, a 34-year-old licensed occupational therapy assistant with over a decade in business and medical management, joins at $1,000 monthly. This shuffle maintains three independent directors out of five, while assigning her to chair the Compensation Committee and serve on Audit and Nominating panels. Smooth transition, no drama.
8-K
Nasdaq compliance warning issued
Bio Green Med Solution's 6% Convertible Exchangeable Preferred Stock fell afoul of Nasdaq's $1 million minimum market value of publicly held shares rule after 30 consecutive business days below the threshold, as notified on September 11, 2025. The company has until March 10, 2026, to regain compliance and keep trading on Nasdaq Capital Market. Common stock remains unaffected. It plans to monitor and explore options. Delisting looms if unmet.
8-K
Acquisition of Fitters completed
Bio Green Med Solution completed its acquisition of Fitters Sdn. Bhd. on September 12, 2025, issuing 699,158 common shares—19.99% of outstanding equity—to Fitters' parent in exchange for full ownership. This diversifies the company into fire safety equipment trading, blending it with biopharma roots for broader Malaysian market exposure. Integration now underway. Yet risks loom in merging operations.
BDPT
Bioadaptives, Inc.
0.03+0.00
BGM
BGM Group Ltd.
9.27-0.11
BIOE
Bio Essence Corp.
0.07+0.00
BLFS
BioLife Solutions, Inc.
27.54-0.44
BSEM
BioStem Technologies, Inc.
4.66+0.16
CBIO
Crescent Biopharma, Inc.
12.50+0.00
IMA
ImageneBio, Inc.
8.79+0.09
INBS
Intelligent Bio Solutions Inc.
0.95-0.06
PHBI
Pharmagreen Biotech Inc.
0.00-0.00
RMTG
Regenerative Medical Technology
0.05+0.00